Quantcast

Latest Angiogenesis Stories

2013-08-19 13:06:21

Rapid identification of changes in tumor blood vessels could help avoid ineffective therapies A new way of analyzing data acquired in MR imaging appears to be able to identify whether or not tumors are responding to anti-angiogenesis therapy, information that can help physicians determine the most appropriate treatments and discontinue ones that are ineffective. In their report receiving online publication in Nature Medicine, investigators from the Martinos Center for Biomedical Imaging at...

2013-06-25 23:01:51

BerriProducts LLC, an Oregon-based supplier of premium quality black raspberry products shares news from the recently-attended Berry Health Benefits Symposium on angiogenesis inhibition with an in vitro test on human carcinoid cancer cells Charlotte, North Carolina (PRWEB) June 25, 2013 Dr. Eugene Woltering, Section Chief of Surgical Endocrinology at the Louisiana State University Health Sciences Center in New Orleans presented some results of his work on neuroendocrine tumors (NETS)....

2013-06-12 23:21:18

Our Lady of Lourdes Medical Center and The Heart House participate in clinical study to determine whether a patient´s own stem cells can relieve chronic chest pain caused by coronary artery disease. Camden, New Jersey (PRWEB) June 12, 2013 Our Lady of Lourdes Medical Center and The Heart House are participating in a clinical study to determine whether a patient´s own (autologous), adult, stem cells are safe and can relieve chronic chest pain caused by coronary artery disease, as...

How And Where Breast Tumor Cells Become Dormant And What Causes Them To Become Metastatic
2013-06-03 19:49:37

Lawrence Berkeley National Laboratory The long-standing mystery behind dormant disseminated breast tumor cells and what activates them after years and even decades of latency may have been solved. Researchers with the U.S. Department of Energy (DOE)´s Lawrence Berkeley National Laboratory (Berkeley Lab) have identified the microenvironment surrounding microvasculature — the small blood vessels that transport blood within tissues — as a niche where dormant cancer cells...

2013-06-03 10:48:37

Results of a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group (RTOG) determined that adding bevacizumab to initial treatment for glioblastoma (GBM) did not improve patient overall survival or progression-free survival. Results were reported June 2 during the plenary session of the American Society of Clinical Oncology 2013 Annual Meeting. GBM is the most common primary malignant brain tumor in adults and, despite treatment advances in recent years, the...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'